Trial intelligence / Profile preview

Atorvastatin Immunomodulatory Effects in Early Atherosclerosis

NCT00361283Phase 4Completed

Sponsor
University of Florida
Start
Jun 2004
Primary completion
Dec 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of atorvastatin in atherosclerosis, sponsored by University of Florida. Started Jun 2004; status: completed.

02

Drugs

atorvastatin
03

Conditions

atherosclerosis

Beyond the preview

Go deeper on NCT00361283.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00361283.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call